Trefoil Therapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $28M
Latest Deal Amount
  • Investors
  • 11

Trefoil Therapeutics General Information

Description

Developer of corneal therapeutics intended to facilitate the treatment for ophthalmic diseases. The company's therapy are focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases and help regenerate the endothelial cell layer and eliminate the symptoms associated with this condition that leads to the loss of vision, enabling ophthalmologists to treat patients with severe corneal endothelial diseases and epithelial disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 6330 Nancy Ridge Drive
  • Suite 103
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Trefoil Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 05-Aug-2019 $28M 000.00 0000 Completed Generating Revenue
3. Early Stage VC (Series 1) 05-Jan-2017 00.00 00.00 00.00 Completed Startup
2. Grant 20-Oct-2015 Completed Startup
1. Accelerator/Incubator 01-Jan-2013 Completed Startup
To view Trefoil Therapeutics’s complete valuation and funding history, request access »

Trefoil Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 000
Series 1 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Trefoil Therapeutics’s complete cap table history, request access »

Trefoil Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of corneal therapeutics intended to facilitate the treatment for ophthalmic diseases. The company's therapy ar
Biotechnology
San Diego, CA
12 As of 2021
000.00
000 0000-00-00
00000000000 000.00

0000 000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore m
0000 000000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00000000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaec
0000000000000
San Francisco, CA
000 As of 0000
00000
0.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Trefoil Therapeutics Competitors (46)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aura Biosciences Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00000000 000000000 Formerly VC-backed San Francisco, CA 000 00000 000000&0 00000
000000000 00000000 Formerly VC-backed San Diego, CA 00 00000 000000 - 000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
00000000 000000000 Venture Capital-Backed Vienna, Austria 00.000 0000000000 00.000
You’re viewing 5 of 46 competitors. Get the full list »

Trefoil Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
David Eveleth Ph.D Co-Founder, Chief Executive Officer & Board Member
Schalon Newton Chief Business Officer
Michael Blaber Ph.D Co-Founder & Scientific Advisory Board Member
Kenneth Thomas Ph.D Co-Founder & Scientific Advisory Consultant
Ralph Bradshaw Ph.D Co-Founder & Chairman of Scientific Advisory Board
To view Trefoil Therapeutics’s complete executive team members history, request access »

Trefoil Therapeutics Board Members (8)

Name Representing Role Since
Benjamin McGraw III Self Executive Chairman 000 0000
Benjamin Scruggs Ph.D Hatteras Venture Partners Board Member 000 0000
Christy Shaffer Ph.D Hatteras Venture Partners Board Member 000 0000
David Eveleth Ph.D Trefoil Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
Derek Yoon AJU IB Investment Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Trefoil Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trefoil Therapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Access Biotechnology Corporate Venture Capital Minority 000 0000 000000 0
Bios Partners Venture Capital Minority 000 0000 000000 0
FemHealth Ventures Venture Capital Minority 000 0000 000000 0
AJU IB Investment Venture Capital Minority 000 0000 000000 0
Correlation Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »